US › Healthcare

Tevogen Bio Holdings Inc. (TVGN)

US · Healthcare · Biotechnology

$7.07-0.14%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-5.8M

EPS

$-1.52

EPS estimate

$-2.50

EPS came in at -1.52 against a street estimate of -2.50 — a beat of 39.2%.

Key statistics

Market cap

$46.0M

Forward P/E

0.0

P/B

0.00

Book value

$-4.16

EPS (TTM)

$-6.74

52-week high

$35.20

52-week low

$3.64

50-day MA

$6.99

200-day MA

$8.75

Beta

0.20

Analyst view

with an average price target of $2.00.

Shareholding

Insiders

72.08%

Institutions

1.64%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	0.37%
Morgan Stanley - Brokerage Accounts	0.29%
AQR Capital Management LLC	0.26%
The Goldman Sachs Group Inc	0.22%
Jane Street Group LLC	0.17%
FMR Inc	0.15%
Tower Research Capital LLC	0.02%
UBS Group AG	0.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tevogen Bio Holdings Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.